liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Correlation between dyslipidemia and severity of allergic rhinitis
Otolaryngology Unit, Faculty of Medicine, Suez Canal University, Ismailia, 41611, Egypt.
Otolaryngology Unit, Faculty of Medicine, Suez Canal University, Ismailia, 41611, Egypt.
Otolaryngology Unit, Faculty of Medicine, Suez Canal University, Ismailia, 41611, Egypt.
Medical Biochemistry Units, Suez Canal University, Ismailia, Egypt.ORCID iD: 0000-0001-5394-9082
Show others and affiliations
2018 (English)In: The Egyptian Journal of Otolaryngology, ISSN 1012-5574, Vol. 34, no 2, p. 111-115Article in journal (Refereed) Published
Abstract [en]

Background

Allergic rhinitis is a common problem affecting between 20 and 25% of the population lowering the quality of life (QOL) more than any other disease. Dyslipidemia is known to impact potently the development of atopy as it promotes proatopic Th2 immunity and allergic inflammation.

Objective

The aim was to test the correlation between severity of allergic rhinitis and dyslipidemia.

Materials and methods

A comparative study carried out on 350 allergic rhinitis patients were subjected to full serum lipid assays, visual analog scale assessing their nasal symptoms, and QOL assessment using a seven-point scale.

Results

Patients were divided into two groups (according to their lipid profile): abnormal dyslipidemia group (33%) and normal lipid profile group (67%).

The abnormal dyslipidemia group showed a more intense allergic rhinitis symptoms compared with the normal lipid profile with poor QOL score (1.97).

Conclusion

Dyslipidemia might play an important role in increasing the severity of allergic rhinitis symptoms with impaired patients’ QOL; therefore, its control could achieve better treatment outcomes. 

Place, publisher, year, edition, pages
London, United Kingdom: Springer, 2018. Vol. 34, no 2, p. 111-115
Keywords [en]
allergy; lipid; quality of life; rhinitis
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:liu:diva-184291DOI: 10.4103/ejo.ejo_90_17ISI: 000456830900002OAI: oai:DiVA.org:liu-184291DiVA, id: diva2:1651285
Available from: 2022-04-11 Created: 2022-04-11 Last updated: 2022-05-02Bibliographically approved

Open Access in DiVA

fulltext(100 kB)84 downloads
File information
File name FULLTEXT01.pdfFile size 100 kBChecksum SHA-512
af6cfbe397504a6b89cd900e496ff936bcce80fa333df7407ad23aa8ffc8575b0f03f7c4f0af8a929b5702740fea896edf44069b463a2d10f3a543d043e01818
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records

El-Serafi, Ahmed Taher

Search in DiVA

By author/editor
El-Serafi, Ahmed Taher
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar
Total: 84 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 83 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf